Review
doi: 10.1016/j.cll.2004.03.006.
Macrolide resistance in Streptococci and Haemophilus influenzae
Affiliations
- PMID: 15177849
- DOI: 10.1016/j.cll.2004.03.006
Item in Clipboard
Review
Macrolide resistance in Streptococci and Haemophilus influenzae
Clin Lab Med.
2004 Jun.
Abstract
Antimicrobial resistance is a growing problem among pathogens from respiratory tract infections. b-Lactam resistance rates are escalating among Streptococcus pneumoniae and Haemophilus influenzae. Macrolides are increasingly used for the treatment of respiratory tract infections, but their utility is compromised by intrinsic and acquired resistance. This article analyses macrolide-resistance mechanisms and their worldwide distributions in S pneumoniae, S pyogenes, and H influenzae.
Similar articles
-
Macrolide resistance rates in respiratory pathogens in Slovenia following reduced macrolide use.Int J Antimicrob Agents. 2006 Dec;28(6):537-42. doi: 10.1016/j.ijantimicag.2006.07.023. Epub 2006 Nov 13. Int J Antimicrob Agents. 2006. PMID: 17101264
-
Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.J Antimicrob Chemother. 2004 Aug;54 Suppl 1:i7-15. doi: 10.1093/jac/dkh313. J Antimicrob Chemother. 2004. PMID: 15265831
-
Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.Int J Antimicrob Agents. 2005 Feb;25(2):148-56. doi: 10.1016/j.ijantimicag.2004.09.016. Int J Antimicrob Agents. 2005. PMID: 15664485
-
[Macrolide antibiotics: Streptococcus pneumoniae and Haemophilus influenzae].Enferm Infecc Microbiol Clin. 1996 Oct;14(8):503-4. Enferm Infecc Microbiol Clin. 1996. PMID: 9011211 Review. Spanish. No abstract available.
-
Bacterial resistance in the new millennium. Its impact on antibiotic selection for respiratory tract infections.Postgrad Med. 2000 Dec;108(7 Suppl Contemporaty):5-16. doi: 10.3810/pgm.12.2000.suppl10.51. Postgrad Med. 2000. PMID: 19667544 Review.
Cited by
-
The use of macrolides in treatment of upper respiratory tract infections.Curr Allergy Asthma Rep. 2006 Mar;6(2):171-81. doi: 10.1007/s11882-006-0056-x. Curr Allergy Asthma Rep. 2006. PMID: 16566868 Review.
-
National trends in Azithromycin consumption during 2017-2023 in Kazakhstan: impact of the COVID-19 pandemic and the imperative for enhanced clinical guidelines.Sci Rep. 2025 Feb 21;15(1):6309. doi: 10.1038/s41598-025-91216-4. Sci Rep. 2025. PMID: 39984711 Free PMC article.
-
The Use of Macrolides in Treatment of Upper Respiratory Tract Infections.Curr Infect Dis Rep. 2005 May;7(3):175-184. doi: 10.1007/s11908-005-0031-z. Curr Infect Dis Rep. 2005. PMID: 15847719
-
No development of ciprofloxacin resistance in the Haemophilus species associated with pneumonia over a 10-year study.BMC Infect Dis. 2015 Nov 13;15:514. doi: 10.1186/s12879-015-1267-3. BMC Infect Dis. 2015. PMID: 26567094 Free PMC article.
-
Toward a genome-wide systems biology analysis of host-pathogen interactions in group A Streptococcus.Am J Pathol. 2005 Dec;167(6):1461-72. doi: 10.1016/S0002-9440(10)61232-1. Am J Pathol. 2005. PMID: 16314461 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
